mild cognitive impairment
DiamiR Wins $3.9M in NIH Funding for Neurological Disease Diagnostic Development
The two grants awarded will support DiamiR's development of microRNA diagnostics for mild cognitive impairment, Alzheimer's disease, and Rett syndrome.
Alzheimer's Disease Neuroimaging Initiative Enters Third Phase
The initiative was launched to conduct a large-scale study of cognitive impairment and Alzheimer's disease to advance the discovery of biomarkers of the conditions.